Latest News

Record revenue and margin gains as company diversifies into aerospace and edge data centers.

International divestiture deal and $16M cost savings reshape portfolio strategy.

It's not too late to catch up if you're behind your peers. Just don't tarry if you are.

Regeneron Pharmaceuticals (NASDAQ:REGN) outlined growth opportunities for Dupixent, pipeline catalysts for cemdisiran and continued commercial momentum for EYLEA HD during the Morgan Stanley Global Healthcare Conference. Marion McCourt, Regeneron’s EVP and head of commercial, said Dupixent’s growth

The 4% rule is a helpful estimate, but a three-layer income plan shows exactly where your next retirement payment comes from.

The best investments are sometimes the simplest.

Bird Construction stock has delivered impressive gains. Here’s how its growing project pipeline could support the next phase of infrastructure growth.

The 2026 TSX30 list features five Canadian technology companies whose average return reached an extraordinary 981%.

This under-the-radar consumer discretionary stock boasts a Superscore of 80 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

Executives from Bitcoin mining and digital infrastructure companies said access to energized power, land and data-center development capabilities is creating an opportunity to serve growing artificial intelligence infrastructure demand, while also presenting significant construction, financing and r

Recent pullbacks have created potential opportunities in several quality TSX stocks. Other than dividends, they also offer potential upside if their valuations recover.

L’IA multimodale transforme la manière dont les utilisateurs exploitent l’intelligence artificielle. Capable de comprendre et de combiner plusieurs formats

How important are terrestrial data centers to SpaceX in the near term?

Defense engineering surged 68% as marine tech declined, reshaping revenue mix.

Scotiabank (BNS) stock offers Canadian banking’s top yield at 3.5%. Here’s how quarterly dividend compounding can snowball your returns over time.

The management team did enough to alleviate some investors' fears about worst-case scenarios for the business.

Revenue is catching up to an expensive valuation.

Investors are skeptical about these optimistic forecasts.

Archer Aviation is one of those high-risk, high-reward type investments.

This stock should only be considered by investors with a high risk tolerance.

AI agents can take more actions than humans, creating increasing demands for cybersecurity.

Customer deposits are helping offset cash flow needs at Oracle.

Demand might fall in the future, but shortages remain for now.

The move could boost consumer spending, while also increasing inflationary pressures.

Teva Pharmaceutical Industries (NYSE:TEVA) CEO Richard Francis said the company has progressed from the initial phase of its “Pivot to Growth” plan into its next stage, citing momentum in branded medicines, innovation, generics and biosimilars, as well as improved financial flexibility. Speaking at